RNS Number : 1008T
Aminex PLC
19 June 2024
 

19 June 2024

 

Aminex plc

 ("Aminex" or "the Company")

 

Exercise of Options and Total Voting Rights

 

Aminex announces that it has issued a total of 8,000,000 ordinary shares of €0.001 each following the exercise of options under the Aminex PLC Share Option Scheme and the Aminex PLC Restricted Share Plan (the "Option Shares"). The exercise will provide £61,000 of additional funding to the Company, which will be used for general working capital purposes.

 

Application will be made to the Financial Conduct Authority ("FCA") for the Option Shares to be admitted to the Official Lists and application will be made to the London Stock Exchange for the Option Shares to be admitted to trading on the main market (standard segment) of the London Stock Exchange. It is expected that such admission will become effective and that dealings will commence in the Option Shares at 8.00 a.m. (London time) on or around 26 June 2024.

Following the issue of the Option Shares, which on Admission will rank pari passu with the existing ordinary shares, the enlarged share capital and the total voting rights of the Company will be 4,219,167,024. The Company does not hold any shares in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

For further information:

 


Aminex PLC

+44 203 355 9909

Charles Santos, Executive Chairman




Knights Media & Public Relations

+44 203 653 0200

Jason Knights, Sabina Zawadzki

 


 

Davy

+353 1 679 6363

Brian Garrahy

 

 

Shard Capital

+44 20 7186 9952

Damon Heath

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRSFFFDUELSEDM